Toshihiro Nagato

9PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 24, 2025
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1-Mutant Lung Cancer.

Toshiyuki Tenma, Ryohei Yoshida, Hiraku Yanada

|Sep 14, 2024
Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.

Risa Wakisaka, Hidekiyo Yamaki, Michihisa Kono

|Jan 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.

Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi

|Sep 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes.

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato

Pageof 2